Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial
European Journal of Cancer2019Vol. 123, pp. 162–170
Citations Over TimeTop 10% of 2019 papers
Atul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, V. Sreenivas, Ranjit Kumar Sahoo, Nootan Kumar Shukla, Sanjay Thulkar, Sujoy Pal, Surya V. Deo, Sushmita Pathy, Nihar Ranjan Dash, Sunil Kumar, Sushma Bhatnagar, Rakesh Kumar, Seema Mishra, Peush Sahni, Venkateswaran K. Iyer, Vinod Raina
Related Papers
- → Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review(2014)84 cited
- → Supraadditive effect of 2 ′ ,2 ′ -difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines(1999)149 cited
- → Radiotherapy Combined with Gemcitabine and Oxaliplatin in Pancreatic Cancer Cells(2008)25 cited
- → Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine(2006)6 cited
- Treatment of Advanced Pancreatic Cancer with Combination of Gemcitabine and Oxaliplatin(2005)